AI-extracted from the 10-Q filed 2026-08-06 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
NHC's Q2 FY2026 net patient revenue rose 4.1% YoY to $378.4M on higher census (90.1% vs 89.4%) and per diem rates, while operating margin expanded to 12.0% from 9.1%, aided by a one-time $18.3M management-fee catch-up.
Biggest Revenue Drivers
Inpatient Services$337.3M
Driven by 90.1% average skilled nursing census (vs 89.4%) and a 1.5% higher composite per diem; includes $6.0M from the June 2026 acquisition of five SNFs from National Health Corporation.
Homecare and Hospice$41.1M
Net patient revenue from homecare and hospice agencies.
Biggest Revenue Drivers
Total revenue: $378.4M+4.1% YoY
Inpatient Services$337.3M
Driven by 90.1% average skilled nursing census (vs 89.4%) and a 1.5% higher composite per diem; includes $6.0M from the June 2026 acquisition of five SNFs from National Health Corporation.
Homecare and Hospice$41.1M
Net patient revenue from homecare and hospice agencies.
Largest Expense Items
Salaries, wages, and benefits$241.9M+6.8% YoY
Fell to 59.3% of net operating revenues from 60.4%; includes $3.7M added from newly acquired facilities.
Other operating$94.5M+2.8% YoY
Prior-year quarter included a $3.6M gain on land contributed to a joint venture that reduced the expense base; current quarter includes $1.5M from acquired facilities.
Facility rent$11.5M
Includes $9.99M paid under the NHI master lease, which was terminated after quarter-end upon NHC's $560M purchase of the leased facilities.
Margins: Total costs and expenses fell to 88.0% of net operating revenues from 90.9%, lifting operating margin to 12.0% from 9.1%, mainly due to a lower salaries/wages ratio (59.3% vs 60.4%) as revenue growth outpaced expense growth.
Watch Items from the Filing
The $190.4M marketable equity portfolio is 65.3% concentrated in National Health Investors (NHI) stock ($124.4M); a 10% price move would shift fair value by ~$19.0M.
Other revenues jumped 156.6% YoY partly from a one-time $18,325,000 management fee for pre-2025 services, recognized only now because revenue-recognition criteria were previously unmet; not indicative of run-rate performance.
Subsequent to quarter-end, NHC bought 32 SNFs and 3 ILFs from NHI for $560,000,000, funded by drawing $475,000,000 under a new term loan and $55,000,000 on a new revolver.
Self-insured accrued risk reserves for workers' compensation and professional liability total $121,129,000 amid an industry-wide rise in severity of long-term-care negligence claims.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
About NATIONAL HEALTHCARE CORP (NHC): stock profile, AI score and financials
NATIONAL HEALTHCARE CORP (NHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NHC at 65.2/100 on a composite quality score built from its SEC filings, placing it at rank #490 of 2,925 stocks — the top 25% of the AI-ranked universe. NHC scores in the top quartile across balance sheet strength (83.5). Areas of concern include institutional flow (20.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), NATIONAL HEALTHCARE CORP reports quarterly revenue of $408.0M, net income of $40.3M, an operating margin of 12.0%. Top institutional holders of NHC by reported 13-F value include BlackRock, Morgan Stanley Institutional Investment Advisors, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. NHC trades on the NYSE exchange and files with the SEC under CIK 1047335. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATIONAL HEALTHCARE CORP directly from SEC EDGAR.